A Hopeful Prospect of Riociguat as a Soluble Guanylate Cyclase Stimulator for Management of Pressure Ulcers

E-ISSN： 1875-6220|15|1|20-23

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.15, Iss.1, 2018-04, pp. : 20-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble guanylate cyclase

By Hobbs A.J.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 6, 2000-12 ,pp. : 735-749

Informa Healthcare

Access to resources Recommend Favorite

Soluble guanylate cyclase: the forgotten sibling

By Hobbs A.J.

Trends in Pharmacological Sciences, Vol. 18, Iss. 12, 1997-12 ,pp. : 484-491

Elsevier

Access to resources Recommend Favorite

Activators of the nitric oxide sensor, soluble guanylate cyclase

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1765-1770

Informa Healthcare

Access to resources Recommend Favorite

Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase

By Severina I.S. Bussygina O.G. Pyatakova N.V. Khropov Y.V. Krasnoperov R.A.

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice

By Teng C.-M. Wu C.-C. Ko F.-N. Lee F.-Y. Kuo S.-C.

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 161-166

Elsevier

Access to resources Recommend Favorite